Rauchen và Estrogen

Hartz AJ, He T (2013) Cohort study of risk factors for breast cancer in postmenopausal women. Epidemiol Health 35:e2013003. DOI 10.4178/epih/e2013003 Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women’s health initiative randomized controlled trial. JAMA 288:312–333 Gao CM, Ding JH, Li SP, Liu YT, Qian Y, Chang J, Tang JH, Tajima K (2013) Active and passive smoking, and alcohol drinking and breast cancer risk in Chinese women. Asian Pac J Cancer Prev 14:993–996 Hu FB, Stampfer MJ, Manson JE et al (2000) Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 343:530–537 Gu F, Caporaso NE, Schairer C, Fortner RT, Xu X, Hankinson SE, Eliassen AH, Ziegler RG (2013) Urinary concentrations of estrogens and estrogen metabolites and smoking in caucasian women. Cancer Epidemiol Biomarkers Prev 22:58–68 Michnovicz JJ, Naganuma H, Hershcopf RJ et al (1988) Increased urinary catechol estrogen excretion in female smokers. Steroids 52:69–83 Zhou B, Yang L, Sun Q, Cong R, Gu H, Tang N, Zhu H, Wang B (2008) Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 121:501–508 Olsson H, Bladström A, Ingvar C (2003) Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 102:565–570 Ross RK, Pike MC, Vesey MP (1986) Risk factors for uterine fibroids. Br Med J 293:359–362 Cramer DW, Wilson E, Stillman RJ et al (1986) The relationship of endometriosis to menstrual characteristics, smoking and exercise. JAMA 255:1904–1908 Bjarnason NH, Jorgensen C, Kremmer H, Alexandersen P, Christiansen C (2004) Smoking reduces breast tenderness during oral estrogen-progestogen therapy. Climacteric 7:390–396 Thompson PA, Ambrosone C (2000) Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 27:125–134 Saintot M, Malaveille C, Hautefeuille A, Gerber M (2003) Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk. Int J Cancer 107:652–657 Ishibe N, Hankinson SE, Colditz GA et al (1998) Cigarette smoking, cytochrome P450 1A1 polymorphism, and breast cancer risk in the Nurses’ Health Study. Cancer Res 58:667–671 Cochran CJ, Gallicchio L, Miller SR, Zacur H, Flaws JA (2008) Cigarette smoking, androgen levels, and hot flushes in midlife women. Obstet Gynecol 112:1037–1044 Bjarnason NH, Byrjalsen I, Jorgensen HL, Christiansen C (2007) The influence of smoking on uterine bleeding during sequential oral hormone therapy. Climacteric 10:147–154 Jensen J, Christiansen C (1988) Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Am J Obstet Gynecol 159:820–825 Craig WY, Palomaki GE, Haddow JE (1989) Cigarette smoking and serum lipid and lipoprotein concentration: an analysis of published data. Br Med J 298:784–788 Baron JA, Farahmand BY, Weiderpass E et al (2001) Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med 161:983–988 Iqbal J, Sun L, Cao J et al (2013) Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes. Proc Natl Acad Sci U S A 110:11115–11120 Yoon V, Maalouf NM, Sakhaee K (2012) The effects of smoking on bone metabolism. Osteoporos Int 23:2081–2092 Modena MG, Sismondi P, Mueck AO, Kuttenn F, de Lignieres B, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR; the TREAT Collaborative Group (2005) New evidence regarding hormone replacement therapies is urgently required. Transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas 52:1–10 Kiel DP, Baron JA, Anderson JJ et al (1992) Smoking eliminates the protective effect of oral estrogen on the risk for hip fracture among women. Ann Int Med 116:716–721 de Valk-de Roo GW, Netelenbos JS, Peters-Muller IR et al (1997) Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnover. Maturitas 28:153–162 Cubrilo-Turek M, Stavljenic-Rukavina A, Turek S et al (1999) The usefulness of biochemical markers in predicting the response of hormone replacement therapy in perimenopausal smoking healthy women. Coll Antropol 23:195–201 Leino A, Impivaara O, Kaitsaari M (1997) Effects of HRT on bone in women smokers and alcohol consumers. J Bone Miner Res 12:S355 Bjarnason NH, Jorgensen HL, Christiansen C (2012) Acute and long-term estradiol kinetics in smoking postmenopausal women. Climacteric 15:449–454 Mueck AO, Bühling K (2013) Erhöhte kardiovaskuläre Mortalität in der (späteren) Postmenopause. Durch Östrogenmangel bedingt? Gynäkologische Endokrinologie 11:256–263 Girdler SS, Hinderliter AL, West SG et al (2000) Postmenopausal smokers show reduced hemodynamic benefit from oral hormone replacement. Am J Cardiology 86:590–592 Ylikorkala O, Cacciatore B, Paakari I et al (1998) The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane. Fertil Steril 69:883–888 Geisler J, Omsjo IH, Helle SI et al (1999) Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking. J Endocrinology 162:265–270 Khuder SA, Mutgi AB, Nugent S (2001) Smoking and breast cancer: a meta-analysis. Rev Environ Health 16:253–261 Reynolds P (2013) Smoking and breast cancer. J Mammary Gland Biol Neoplasia 18:15–23 Glantz SA, Johnson KC (2014) The surgeon general report on smoking and health 50 years later: breast cancer and the cost of increasing caution. Cancer Epidemiol Biomarkers Prev 23:37–46 WHI Investigators Writing Group (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA 289:3243–3253 Mueck AO, Seeger H (2014) Risiko von Brustkrebs unter "hormone replacement therapy". Klinische Daten und experimentell-biologische Plausibilität. Gynäkologische Endokrinologie 12:149–155 Stanczyk FZ (2011) Editorial. Can the increase in breast cancer observed in the estrogen plus progestin arm of the Women’s Health Initiative trial be explained by progesterone receptor membrane component 1? Menopause 18:833–834 Neubauer H, Ma Q, Zhou J, Yu Q, Ruan X, Seeger H, Fehm T, Mueck AO (2013) Possible role of PGRMC1 in breast cancer development. Climacteric 16:509–513 Band PR, Le ND, Fang R, Deschamps M (2002) Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 360:1044–1049 Russo J, Russo IH (2011) The role of the basal stem cell of the human breast in normal development and cancer. Adv Exp Med Biol 720:121–34 Service RF (1998) New role for estrogen in cancer? Science 279(5357):1631–1633 Seeger H, Wallwiener D, Krämer E, Mueck AO (2006) Comparison of possible carcinogenic estradiol metabolites: Effects on proliferation, apoptosis and metastasis of human breast cancer cells. Maturitas 54:72–77 Berstein LM, Tsyrlina EV, Kolesnik OS et al (2000) Catecholestrogens excretion in smoking and non-smoking postmenopausal women receiving estrogen replacement therapy. J Steroid Biochem Mol Biol 72:143–147 Michnovicz JJ, Hershcopf RJ, Naganuma H et al (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 315:1305–1309 Lippert TH, Seeger H, Mueck AO (2001) Pharmacology and toxicology of different estrogens. Gynecol Endocrinol 15(Suppl 4):26–33 Mueck AO, Ruan X (2011) Benefits and risks during HRT – main safety issue breast cancer. Horm Mol Biol Clin Invest 5:105–116 Lippert TH, Seeger H, Mueck AO (2000) The impact of estrogen metabolites on carcinogenesis. Steroids 65:357–369 Polesel J, Serraino D, Zucchetto A, Lucenteforte E, Dal Maso L, Levi F, Negri E, Montella M, Franceschi S, Talamini R, La Veccia C (2009) Cigarette smoking and endometrial cancer risk: the modifying effect of obesity. Eur J Cancer Prev 18:476–481 Mueck AO, Seeger H, Lippert TH (2002) Estradiol metabolism and malignant disease. Review. Maturitas 43:1–10 Mueck AO, Seeger H (2010) 2-Methoxyestradiol - biology and mechanism of action. Steroids 75:625–631 Seeger H, Mueck AO, Lippert TH (1998) Estradiol metabolism during oral and transdermal estradiol replacement therapy in the postmenopause. Horm Metab Res 30:598–601 Seeger H, Mueck AO, Lippert TH (2000) Effect of norethisterone acetate on estrogen metabolism in postmenopausal women. Horm Metab Res 32:436–439 Mueck AO, Seeger H, Gräser T, Lippert TH (2001) Effect of postmenopausal HRT and of oral contraceptives on estradiol metabolism. Horm Metab Res 33:744–747